Petr Funka,
Kamil Motykaa,
Petr Džubákb,
Pawel Znojekb,
Soňa Gurskáb,
Joachim Kuszc,
Claire McMastera,
Marián Hajdúchb and
Miroslav Soural*a
aDepartment of Organic Chemistry, Institute of Molecular and Translational Medicine, Faculty of Science, Palacký University, 771 46 Olomouc, Czech Republic. E-mail: soural@orgchem.upol.cz
bInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Hněvotínská 5, CZ-775 15 Olomouc, Czech Republic
cInstitute of Physics, University of Silesia, 4 Uniwersytecka Street, Pl-40-007 Katowice, Poland
First published on 28th May 2015
The synthesis of 3-hydroxyquinoline-4(1H)-one derivatives bearing substituted phenyl in position 2 and variously substituted carboxamide group in position 5 is described, with use of 3-nitrophthalic anhydride, α-haloketones and primary amines as the starting materials. The synthetic approach was inspired by the preparation of analogous derivatives reported previously. However, a different strategy had to be developed with the corresponding bis(phenacyl)-3-aminophthalates as the key intermediates. Synthesized hydroxyquinolinones, as well as their intermediates, were tested for their cytotoxic activity towards various cancer and non-malignant cell lines. The fluorescent properties of these compounds have also been evaluated. In both fields, interesting data were obtained and compared to isomeric compounds that have been studied in the past.
![]() | ||
Fig. 1 Solid-phase strategy for the preparation of 6-8 carboxamides described previously17,20 and properties of selected compounds. |
Despite detailed research into this field, a aforementioned studies were incomplete due to the impossibility to apply the original solid-phase approach to the preparation of isomers with the carboxamide group located in position 5. To reach this goal, we switched to traditional solution-phase chemistry to find a synthetic strategy for the desired compounds. Herein we describe the method development, its application for the preparation of a set of target derivatives and comparisons of their cytotoxic/fluorescence properties with the corresponding 6-8-carboxamides.
![]() | ||
Scheme 1 Attempt to synthesize methyl 2-amino-6-(propylcarbamoyl)benzoate 7 according to previously reported procedure. |
The alternative strategy was based on the preparation of bis(phenacyl)-3-aminophthalates 13 as the precursors for the formation of the 3HQ scaffold. Due to limited purity after catalytic reduction of compound 2, dimethylester 8 was synthesized first, via the formation of the corresponding acylchloride. Subsequent reduction afforded compound 9 in an excellent purity which was smoothly hydrolyzed to obtain pure 3-aminophthalic acid 10. Compound 10 was alkylated with bromoacetophenone to give bis(phenacyl)-3-aminophtalate 13a. It is worth mentioning that an alternative strategy based on the hydrolysis of compound 8 followed by alkylation of intermediate 11 failed in the stage of catalytic hydrogenation of compound 12, which afforded only a complex mixture of compounds (Scheme 2). Cyclization of intermediate 13a to 3HQ derivative 14a was performed with use of TFA as described earlier for similar derivatives.12 The final step of the sequence was aminolysis of compound 14a with propylamine to obtain final 3HQ 15a. Two methods have been developed: reflux with propylamine in chloroform (10% solution) was successfully used on a small scale (milligram quantities). On a larger scale (quantities above 100 mg), the method was not successful due to an incomplete conversion and chloroform had to be replaced by DMF.
For fluorescence and biological assay purposes we also managed to develop re-esterification of compound 14a to prepare methyl derivative 16a (Scheme 3).
With use of developed procedures, a set of model compounds (Table 1) were prepared from various bromoacetophenones and amines (Fig. 2). To allow for the comparative study of the structure–cytotoxicity and structure–fluorescence relationship, we selected the same building blocks and their combinations as used previously for the preparation of 6-8 carboxamides.20,21 The developed procedure was generally applicable, only the cyclization of intermediate 13h had to be performed in anhydrous phosphoric acid instead of TFA which did not work.
Entry | Cmpd | R1 | R2 | Yielda (%) |
---|---|---|---|---|
a Calculated after the cyclization step. | ||||
1 | 13a | H | — | 70 |
2 | 13b | 3,5-DiCl-4-NH2 | — | 68 |
3 | 13c | 4-CH3 | — | 84 |
4 | 13d | 4-OCH3 | — | 65 |
5 | 13e | 4-F | — | 82 |
6 | 13f | 3-Br | — | 77 |
7 | 13g | 3-NO2-4-Cl | — | 68 |
8 | 13h | 3-NO2-4-N-PIP | — | 87 |
9 | 14a | H | — | 88 |
10 | 14b | 3,5-DiCl-4-NH2 | — | 87 |
11 | 14c | 4-CH3 | — | 93 |
12 | 14d | 4-OCH3 | — | 84 |
13 | 14e | 4-F | — | 90 |
14 | 14f | 3-Br | — | 95 |
15 | 14g | 3-NO2-4-Cl | — | 81 |
16 | 14h | 3-NO2-4-N-PIP | — | 79 |
17 | 15a | H | Propyl | 35 |
18 | 15b | 3,5-DiCl-4-NH2 | Propyl | 45 |
19 | 15c | 4-CH3 | Propyl | 64 |
20 | 15d | 4-OCH3 | Propyl | 40 |
21 | 15e | 4-F | Propyl | 31 |
22 | 15f | 3-Br | Propyl | 81 |
23 | 15g | 3,5-DiCl-4-NH2 | Hydroxyethyl | 35 |
24 | 15h | 3,5-DiCl-4-NH2 | ![]() |
24 |
25 | 15i | 3,5-DiCl-4-NH2 | Benzyl | 34 |
26 | 15j | 3,5-DiCl-4-NH2 | H | 30 |
27 | 16a | H | — | 34 |
28 | 16b | 3,5-DiCl-4-NH2 | — | 32 |
The difference could be explained by the strong intramolecular hydrogen bonding in the structure of 8-carboxamides which does not exist in the case of the 6- and 7-carboxamide analogues (Fig. 3).
A different situation was expected in the structure of 5-carboxamides; the steric repulsion between two carbonyl groups enforces the conformation in which the carboxamide is not in the same plain with the aromatic moiety and conjugation is lost. This fact has been proved by X-ray analysis of compound 15a (Chart 1). However, the consequence of this feature to the resulting fluorescence and biological properties was unclear.
![]() | ||
Chart 1 X-ray analysis of compound 15a. Hydrogen atoms have been omitted for the sake of clarity. Displacement ellipsoids are drawn at the 50% probability level. |
From the initial results of the fluorescence study in dimethyl sulfoxide (DMSO), it was evident that the existence of the dual fluorescence spectrum was not significantly affected by the location of the carboxamide group at position 5. Although the intensity of the lower wavelength maximum was reduced (Fig. 4, solid line), it was still noticeable and resembled the emission spectra of 7-carboxamides.22 On the other hand, the presence of the methyl ester instead of carboxamide (3HQs 16a, 16b) led to complete loss of the emission maximum at lower wavelength and the dual fluorescence spectrum was not detected. 3HQs 14 with the phenacyl ester moiety did not give consistent results: for the majority of them the dual fluorescence spectrum was lost, only two 3HQs 14a and 14f provided the second (higher wavelength) emission maximum. In contrast, 3HQ 14g afforded only the lower wavelength emission maximum (Table 2) and compound 14h did not exhibit any fluorescence at all. To highlight the key effect of the 3HQ scaffold, we have also studied bis(phenacyl)esters 13. Although their fluorescence has been observed, the dual fluorescence spectra were not obtained and their emission maximum was significantly lower compared to 3HQs (520–560 nm for 3HQs 14–16, 454–480 for compounds 13).
Entry | Cmpd | λexca (nm) | λem,1b (nm) | λem,2c (nm) | I1/I2d | φe (%) |
---|---|---|---|---|---|---|
a λex, excitation wavelength.b λem,1, the fluorescence emission maximum at lower wavelengths.c λem,2, the fluorescence emission maximum at higher wavelengths.d I1/I2, the ratio of fluorescence maxima intensities.e φ, fluorescence quantum yield (determined with quinine sulphate in 0.5 M sulphuric acid (φ = 0.577 (ref. 25)), taken as a reference fluorescence standard). | ||||||
1 | 13a | 394 | 474 | — | — | 43.43 |
2 | 13b | 373 | 467 | — | — | 16.65 |
3 | 13c | 390 | 464 | — | — | 48.67 |
4 | 13d | 371 | 454 | — | — | 20.15 |
5 | 13e | 373 | 462 | — | — | 3.66 |
6 | 13f | 394 | 474 | — | — | 19.87 |
7 | 13g | 394 | 472 | — | — | 5.43 |
8 | 13h | 395 | 480 | — | — | 0.17 |
9 | 14a | 402 | 474 | 555 | 0.1158 | 11.20 |
10 | 14b | 413 | — | 560 | — | 19.57 |
11 | 14c | 405 | — | 555 | — | 10.44 |
12 | 14d | 403 | — | 560 | — | 28.91 |
13 | 14e | 404 | — | 556 | — | 10.84 |
14 | 14f | 407 | 478 | 555 | 0.0990 | 7.26 |
15 | 14g | 419 | 481 | — | — | 0.72 |
16 | 14h | — | — | — | — | — |
17 | 15a | 403 | 449 | 527 | 0.1024 | 36.14 |
18 | 15b | 409 | 467 | 531 | 0.0627 | 37.63 |
19 | 15c | 404 | 464 | 526 | 0.1025 | 14.76 |
20 | 15d | 400 | 454 | 525 | 0.1146 | 38.61 |
21 | 15e | 404 | 455 | 528 | 0.1123 | 42.54 |
22 | 15f | 403 | 457 | 520 | 0.0698 | 30.80 |
23 | 15g | 415 | 456 | 532 | 0.0602 | 42.74 |
24 | 15h | 411 | 468 | 532 | 0.0893 | 24.11 |
25 | 15i | 410 | 461 | 531 | 0.0683 | 37.10 |
26 | 15j | 412 | 471 | 530 | 0.0855 | 25.51 |
27 | 16a | 402 | — | 547 | — | 39.78 |
28 | 16b | 416 | — | 554 | — | 29.96 |
Quantum yields within the group of 5-carboxamides 15 were mostly similar, although slightly lower compared to analogical 6/7-carboxamides.22 Nonetheless, there was no clear relationship between their values and the structural features of these molecules. A quite different situation was observed for phenacyl-3HQs 14 which provided a wide range of values from 0.72% to 28.9%. It could be concluded that the presence of 2-phenyl with strongly electron withdrawing groups (such as nitro, fluoro) significantly diminished the quantum yields (compounds 14g and 14h), whereas compounds with electron-donating groups (such as methoxy, amino, methyl) provided higher values. Similar dependence have been observed for bis(phenacyl)esters 13.
The study was further expanded to evaluate the relationship between fluorescence properties and pH. For this purpose, representative compounds 13c, 14a, 15d and 16a with the highest quantum yields and/or dual-band spectra were selected. The pH measurements were performed in a solution consisting of 9:
1 v/v 0.1 M phosphate buffer–dimethyl sulfoxide with the concentration of investigated compound being 10 μg mL−1. Surprisingly, in aqueous solution the emission spectra totally lost their dual character. The loss of the dual shape of emission spectra did not enable us to apply the ratio of the maximum intensities as a signal. The intensity ratio does not usually depend on the label concentration which is an important advantage in complex biological systems, such as cells or tissues, where the local concentration of the dye cannot be easily controlled and generally the label is not distributed homogenously. In each studied case, the emission spectra retained the same shape at different pHs, whereas the fluorescence intensity changed (Fig. 5). The maximum fluorescence intensity was reached at pH 3.60, 6.41, 5.23 and 5.75 for 13c, 14a, 15d and 16a, respectively. The pH dependences of fluorescence intensity had a similar shape for all investigated compounds: at acidic pH values the fluorescence intensity increased with increasing pH, reached the maximum and then gradually decreased (Fig. 5, below). In spite of the fact that the ratiometric measurement was not possible, the pH dependence of fluorescence intensity for 13c was linear (y = −8.7349x + 132.15, R2 = 0.9936) in the pH range 4.62–9.22 which could be beneficial, especially for biological measurement.
Cmpd | CCRF-CEM | CEM-DNR | K562 | K562-TAX | A549 | HCT116 | HCT116 p53−/− | U2OS | BJ |
---|---|---|---|---|---|---|---|---|---|
13a | >50 | >50 | >50 | >50 | >50 | 43 | >50 | >50 | >50 |
13b | >50 | 48 | >50 | >50 | >50 | >50 | >50 | >50 | >50 |
13c | >50 | 46 | >50 | >50 | >50 | >50 | >50 | >50 | >50 |
13d | >50 | >50 | >50 | >50 | >50 | >50 | >50 | >50 | >50 |
13e | >50 | >50 | >50 | >50 | >50 | >50 | >50 | >50 | >50 |
13g | 12 | 37 | 17 | 8.3 | >50 | 30 | 19 | 12 | >50 |
13h | >50 | >50 | >50 | >50 | >50 | >50 | >50 | >50 | >50 |
14a | 2.7 | 8.1 | 8.6 | 6.0 | 9.5 | 12 | 4.0 | 10 | 10 |
14b | 0.8 | 4.5 | 1.5 | 0.8 | 2.3 | 1.6 | 1.4 | 2.4 | 25 |
14c | 40 | >50 | >50 | 42 | >50 | >50 | >50 | >50 | >50 |
14d | 2.7 | 8.8 | 7.6 | 4.2 | 13 | 6.5 | 4.0 | 10 | >50 |
14e | 2.2 | 6.7 | 13 | 4.0 | 23 | 3.5 | 3.3 | 5.4 | 36 |
14f | 2.3 | 2.3 | 1.3 | 4.6 | 6.4 | 3.0 | 2.7 | 10 | 34 |
14g | 20 | 24 | 38 | 6.2 | 12 | 8.7 | 11 | 7.7 | 26 |
14h | 32 | >50 | >50 | 13 | >50 | 12 | 32 | >50 | >50 |
15a | 10 | 26 | >50 | 31 | >50 | 20 | 19 | 23 | >50 |
15b | 7.7 | 23 | 15 | 8.8 | 34 | 7.5 | 7.2 | 12 | 34 |
15c | 22 | 39 | 32 | 26 | >50 | 27 | 20 | >50 | >50 |
15d | 28 | 44 | 48 | 35 | >50 | 30 | 27 | >50 | >50 |
15e | 16 | 36 | >50 | 32 | >50 | 21 | 17 | 46 | 45 |
15f | 4.3 | 13 | 25 | 10 | 24 | 7.9 | 8.0 | 14 | >50 |
15g | 31 | >50 | 49 | 48 | >50 | 42 | 39 | 47 | >50 |
15h | 34 | >50 | 36 | >50 | 48 | 25 | 27 | 46 | 40 |
15i | 3.3 | 10 | 2.5 | 4.6 | 6.9 | 24 | 4.0 | 10 | 8.6 |
15j | 34 | 48 | 45 | 30 | 49 | 20 | 18 | 27 | 45 |
16a | 15 | 49 | >50 | >50 | >50 | >50 | 46 | 17 | >50 |
16b | 4.7 | 6.7 | 5.8 | 4.6 | 27 | 5.5 | 4.6 | 9.3 | 9.8 |
As in the case of bisphenacyl-2-aminoterephthalates,2 the corresponding bisphenacyl-3-aminophthalates 13 did not exhibit significant cytotoxic activity. However, an exception has been observed for compound 13g which showed a medium cytotoxicity against K562-TAX, U2OS and CEM cells. Within the group of HQ-5-carboxamides 15, the similar SAR pattern as for analogical 6-8 carboxamides was observed: the highest activity was detected for 2-(3,5-dichloro-4-aminophenyl)-3HQs with unpolar N-alkyl substituents (15b:N-propyl and 15i:N-benzyl), whereas the unsubstituted carboxamide 15j and compounds with polar (15g:N-hydroxyethyl) or basic (15h:N-piperidinyl-ethyl) ligands were not cytotoxic. Structural change of propylamides (15a,b) to the corresponding methylesters (16a,b) provided approximately the same results. On the other hand, cytotoxicity of 3HQs-5-phenacylesters 14 was in general significantly higher, with compound 14b being the most active derivative from the whole set. IC50 of aminophthalate 14b for A-549, K56A, CEM, K562-TAX and CEM-DNR was comparable to isomeric aminoterephthalate.2 In contrast, 4-methylphenyl phthalate derivative 14c was inactive compared to isomeric aminoterephthalate that exhibited micromolar IC50 for all tested lines.2 The reversed dependence was observed for the unsubstituted phenacylester 14a (Fig. 6). The majority of active compounds were less active against the CEM-DNR multidrug resistant cell line overexpressing the multidrug resistance protein 1 (MRP-1), than against highly chemosensitive parental CCRF-CEM cell line. However, the opposite pattern was identified in the case of P glycoprotein (Pgp-1) overexpressing multidrug resistant K562-TAX cell line which was more sensitive than parental K562 cell line. Interestingly, CEM-DNR cells also lack topoisomerase IIα gene, which has been previously reported as a molecular target for quinolone derivatives. It is suggesting either the topoisomerase IIα as a molecular target for 3HQs-5-phenacylesters 14 or involvement of MPR-1 but not Pgp-1 in drug efflux and resistance mechanisms.26 The growth inhibitory activity of compounds against human colorectal cancer cell line HCT116 and its p53 deficient counterpart (HCT116p53−/−) were similar, thus indicating independence of cell death mechanism on the p53 gene. The therapeutic index of the most active compound 14b ranged from 15–30 for majority of cell lines, suggesting preferential activity against malignant cells.
![]() | ||
Fig. 6 Example of 3HQs-phenacylesters cytotoxicity dependence on the location of the ester group (for K562 cell line). |
Finally, two representative compounds were subjected to the fluorescent microscopy assay. We selected the most cytotoxic compound 14b along with the most active carboxamide derivative 15i. The results are depicted in Chart 2. The microscopy imaging is showing that the fluorescent compounds are penetrating cellular membranes of living cells. The highest intensity of the fluorescence and accumulation of the compound was observed in the cytoplasm, with discrete nuclear spots. Maximum cytoplasmic positivity was seen in perinuclear region, the staining pattern was overlapping in both emission wavelengths. Detailed subcellular localization is to be determined in future studies.
![]() | ||
Chart 2 U2OS osteosarcoma cancer cells treated with 14b (first row) and 15i (second row). Full size images are available in ESI.† |
Footnote |
† Electronic supplementary information (ESI) available. CCDC 1057862. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5ra08733c |
This journal is © The Royal Society of Chemistry 2015 |